TROP2

Clinical trials for TROP2 explained in plain language.

Never miss a new study

Get alerted when new TROP2 trials appear

Sign up with your email to follow new studies for TROP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New PET scan could predict who benefits from targeted lung cancer therapy

Disease control Not yet recruiting

This study investigates a drug called sacituzumab govitecan, which targets the TROP2 protein, in people with advanced non-small cell lung cancer that has stopped responding to standard EGFR-targeted treatments. Researchers are also comparing two types of PET/CT scans—one standard…

Matched conditions: TROP2

Phase: PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

TROP2

Get alerted when new TROP2 trials appear

New PET scan could predict who benefits from targeted lung cancer therapy